How much revenue did China Healthwise Holdings generate this year?
China Healthwise Holdings has achieved a revenue of 146.32 M HKD this year.
In 2024, China Healthwise Holdings's sales reached 146.32 M HKD, a 3% difference from the 142.06 M HKD sales recorded in the previous year.
YEAR | REVENUE (undefined HKD) | GROSS MARGIN (%) |
---|---|---|
2023 | 146.32 | 41,21 |
2022 | 142.06 | 37,50 |
2021 | 170.08 | 53,50 |
2020 | 137.85 | 44,29 |
2019 | 309.97 | 28,25 |
2018 | 451.62 | 36,48 |
2017 | 561.19 | 28,81 |
2016 | 319.22 | 6,94 |
2015 | 352.8 | 17,80 |
2014 | 389.43 | 28,74 |
2013 | 193.7 | 30,77 |
2012 | 209.3 | 25,51 |
2011 | 419.8 | 15,58 |
2010 | 538 | 16,51 |
2009 | 402.4 | 19,83 |
2008 | 637.2 | 18,77 |
2007 | 799.1 | 24,44 |
2006 | 704.8 | 29,54 |
2005 | 750.6 | 28,74 |
2004 | 774.7 | 26,86 |
3 years
5 years
10 years
25 Years
Max
Gain insights into China Healthwise Holdings, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by China Healthwise Holdings from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects China Healthwise Holdings’s net earnings, an ultimate measure of its financial health and profitability.
Observe the yearly bars to understand the annual performance and growth of China Healthwise Holdings. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
The expected values for the forthcoming years offer investors a glimpse into China Healthwise Holdings’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Leveraging the comparison between Revenue and EBIT helps in assessing China Healthwise Holdings’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on China Healthwise Holdings’s growth potential.
Date | China Healthwise Holdings Revenue | China Healthwise Holdings EBIT | China Healthwise Holdings Net Income |
---|---|---|---|
2023 | 146.32 M HKD | -4.93 M HKD | -134.56 M HKD |
2022 | 142.06 M HKD | -12.74 M HKD | -54.27 M HKD |
2021 | 170.08 M HKD | 26.98 M HKD | -103.05 M HKD |
2020 | 137.85 M HKD | 4.29 M HKD | -25.22 M HKD |
2019 | 309.97 M HKD | -23.62 M HKD | -124.35 M HKD |
2018 | 451.62 M HKD | -10.44 M HKD | -95.32 M HKD |
2017 | 561.19 M HKD | -44.36 M HKD | -186.1 M HKD |
2016 | 319.22 M HKD | -167.91 M HKD | -241.94 M HKD |
2015 | 352.8 M HKD | -82.36 M HKD | -81.32 M HKD |
2014 | 389.43 M HKD | -19.14 M HKD | 17.04 M HKD |
2013 | 193.7 M HKD | -13.9 M HKD | 5.3 M HKD |
2012 | 209.3 M HKD | 2.4 M HKD | 2.2 M HKD |
2011 | 419.8 M HKD | 4.1 M HKD | 77.6 M HKD |
2010 | 538 M HKD | -107.7 M HKD | -197.5 M HKD |
2009 | 402.4 M HKD | -145.9 M HKD | -175 M HKD |
2008 | 637.2 M HKD | -135.4 M HKD | -288.8 M HKD |
2007 | 799.1 M HKD | 4.1 M HKD | 4.4 M HKD |
2006 | 704.8 M HKD | -9.4 M HKD | -37.2 M HKD |
2005 | 750.6 M HKD | 38.9 M HKD | 16.7 M HKD |
2004 | 774.7 M HKD | 35.9 M HKD | 20.3 M HKD |
Revenue | EBIT | Net Income | |
---|---|---|---|
2004 | 774.7 M HKD | 35.9 M HKD | 20.3 M HKD |
2005 | 750.6 M HKD | 38.9 M HKD | 16.7 M HKD |
2006 | 704.8 M HKD | -9.4 M HKD | -37.2 M HKD |
2007 | 799.1 M HKD | 4.1 M HKD | 4.4 M HKD |
2008 | 637.2 M HKD | -135.4 M HKD | -288.8 M HKD |
2009 | 402.4 M HKD | -145.9 M HKD | -175 M HKD |
2010 | 538 M HKD | -107.7 M HKD | -197.5 M HKD |
2011 | 419.8 M HKD | 4.1 M HKD | 77.6 M HKD |
2012 | 209.3 M HKD | 2.4 M HKD | 2.2 M HKD |
2013 | 193.7 M HKD | -13.9 M HKD | 5.3 M HKD |
2014 | 389.43 M HKD | -19.14 M HKD | 17.04 M HKD |
2015 | 352.8 M HKD | -82.36 M HKD | -81.32 M HKD |
2016 | 319.22 M HKD | -167.91 M HKD | -241.94 M HKD |
2017 | 561.19 M HKD | -44.36 M HKD | -186.1 M HKD |
2018 | 451.62 M HKD | -10.44 M HKD | -95.32 M HKD |
2019 | 309.97 M HKD | -23.62 M HKD | -124.35 M HKD |
2020 | 137.85 M HKD | 4.29 M HKD | -25.22 M HKD |
2021 | 170.08 M HKD | 26.98 M HKD | -103.05 M HKD |
2022 | 142.06 M HKD | -12.74 M HKD | -54.27 M HKD |
2023 | 146.32 M HKD | -4.93 M HKD | -134.56 M HKD |
3 years
5 years
10 years
25 Years
Max
The gross margin, expressed as a percentage, delineates the gross profit made from the China Healthwise Holdings's sales revenue. A higher gross margin percentage indicates that the China Healthwise Holdings retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT margin represents the China Healthwise Holdings's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
The revenue margin demonstrates the China Healthwise Holdings's total revenue generated. When comparing the revenue margin year over year, investors can gauge the China Healthwise Holdings's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the China Healthwise Holdings. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the China Healthwise Holdings's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
China Healthwise Holdings Gross margin | China Healthwise Holdings Profit margin | China Healthwise Holdings EBIT margin | China Healthwise Holdings Profit margin |
---|---|---|---|
2023 | 41.21 % | -3.37 % | -91.96 % |
2022 | 37.5 % | -8.97 % | -38.21 % |
2021 | 53.5 % | 15.86 % | -60.59 % |
2020 | 44.29 % | 3.11 % | -18.3 % |
2019 | 28.25 % | -7.62 % | -40.12 % |
2018 | 36.48 % | -2.31 % | -21.11 % |
2017 | 28.81 % | -7.9 % | -33.16 % |
2016 | 6.94 % | -52.6 % | -75.79 % |
2015 | 17.8 % | -23.35 % | -23.05 % |
2014 | 28.74 % | -4.92 % | 4.37 % |
2013 | 30.77 % | -7.18 % | 2.74 % |
2012 | 25.51 % | 1.15 % | 1.05 % |
2011 | 15.58 % | 0.98 % | 18.48 % |
2010 | 16.51 % | -20.02 % | -36.71 % |
2009 | 19.83 % | -36.26 % | -43.49 % |
2008 | 18.77 % | -21.25 % | -45.32 % |
2007 | 24.44 % | 0.51 % | 0.55 % |
2006 | 29.54 % | -1.33 % | -5.28 % |
2005 | 28.74 % | 5.18 % | 2.22 % |
2004 | 26.86 % | 4.63 % | 2.62 % |
Gross margin | EBIT margin | Profit margin | |
---|---|---|---|
2004 | 26.86 % | 4.63 % | 2.62 % |
2005 | 28.74 % | 5.18 % | 2.22 % |
2006 | 29.54 % | -1.33 % | -5.28 % |
2007 | 24.44 % | 0.51 % | 0.55 % |
2008 | 18.77 % | -21.25 % | -45.32 % |
2009 | 19.83 % | -36.26 % | -43.49 % |
2010 | 16.51 % | -20.02 % | -36.71 % |
2011 | 15.58 % | 0.98 % | 18.48 % |
2012 | 25.51 % | 1.15 % | 1.05 % |
2013 | 30.77 % | -7.18 % | 2.74 % |
2014 | 28.74 % | -4.92 % | 4.37 % |
2015 | 17.8 % | -23.35 % | -23.05 % |
2016 | 6.94 % | -52.6 % | -75.79 % |
2017 | 28.81 % | -7.9 % | -33.16 % |
2018 | 36.48 % | -2.31 % | -21.11 % |
2019 | 28.25 % | -7.62 % | -40.12 % |
2020 | 44.29 % | 3.11 % | -18.3 % |
2021 | 53.5 % | 15.86 % | -60.59 % |
2022 | 37.5 % | -8.97 % | -38.21 % |
2023 | 41.21 % | -3.37 % | -91.96 % |
The sales figures of China Healthwise Holdings originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.
Analyzing China Healthwise Holdings’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.
Investors often scrutinize China Healthwise Holdings's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.
Increases in China Healthwise Holdings’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.
China Healthwise Holdings has achieved a revenue of 146.32 M HKD this year.
The revenue of China Healthwise Holdings has increased by 3% increased compared to the previous year.
The revenue of a company is an important indicator of its financial performance and attractiveness for investors.
The revenue of China Healthwise Holdings is influenced by various factors, including the demand for its products and services, market conditions, and prices.
Revenue is typically measured in units referring to the sale of goods and services provided by the company.
An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.
A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.
The revenue of China Healthwise Holdings is an important indicator of financial performance and attractiveness for investors.
A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.
Over the past 12 months, China Healthwise Holdings paid a dividend of 0.02 HKD . This corresponds to a dividend yield of about 33.4 %. For the coming 12 months, China Healthwise Holdings is expected to pay a dividend of 0 HKD.
The current dividend yield of China Healthwise Holdings is 33.4 %.
China Healthwise Holdings pays a quarterly dividend. This is distributed in the months of January, September, January, October.
China Healthwise Holdings paid dividends every year for the past 0 years.
For the upcoming 12 months, dividends amounting to 0 HKD are expected. This corresponds to a dividend yield of 0 %.
China Healthwise Holdings is assigned to the 'Cyclical consumption' sector.
To receive the latest dividend of China Healthwise Holdings from 9/22/2005 amounting to 0.005 HKD, you needed to have the stock in your portfolio before the ex-date on 9/1/2005.
The last dividend was paid out on 9/22/2005.
In the year 2023, China Healthwise Holdings distributed 0 HKD as dividends.
The dividends of China Healthwise Holdings are distributed in HKD.
Our stock analysis for China Healthwise Holdings Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Healthwise Holdings Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.